Zimmer Biomet Announces Fourth Quarter and Full-Year 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY23 Guidance
February 3, 2023 6:34 AM ESTZimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $1.88, $0.05 better than the analyst estimate of $1.83. Revenue for the quarter came in at $1.83 billion versus the consensus estimate of $1.76 billion.
GUIDANCE:
Zimmer Biomet Holdings sees FY2023 EPS of $6.95-$7.15, versus the... More
